Finance

Beta
Lists
CUE:NASDAQ
Cue Biopharma Inc
$24.53
-9.45%
(-2.56) 1D
Jun 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
$27.09
High
$28.94
Low
$23.20
Mkt. cap
99.24M
Avg. vol.
901.47K
Volume
86.60K
52-wk high
$41.36
52-wk low
$4.97
EPS
-$5.52
Beta
2.52
Shares outstanding
4.20M
No. of employees
29
Open
$27.09
High
$28.94
Low
$23.20
Mkt. cap
99.24M
Avg. vol.
901.47K
Volume
86.60K
52-wk high
$41.36
52-wk low
$4.97
EPS
-$5.52
Beta
2.52
Shares outstanding
4.20M
No. of employees
29
News stories
From sources across the web
About Cue Biopharma Inc
CEO-
Employees29
Founded2014
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitecuebiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.95M
2.15M
21.94M
5.69M
Cost of goods sold
7.91M
4.15M
15.93M
-
Cost of revenue
7.91M
4.15M
15.93M
-
Research and development expenses
-
-
-
6.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.68M
5.54M
4.05M
4.15M
Operating expense
3.68M
5.54M
4.05M
11.05M
Total operating expenses
11.59M
9.69M
19.98M
11.05M
Operating income
-8.64M
-7.54M
1.96M
-5.36M
Other non operating income
-
-
-
10.00K
EBT including unusual items
-8.48M
-7.45M
2.08M
-5.18M
EBT excluding unusual items
-8.48M
-7.40M
2.06M
-5.18M
Income tax expense
-
-
500.00K
-
Effective tax rate
-
-
23.98%
-
Other operating expenses
-
-
-
-
Net income
-8.48M
-7.45M
1.58M
-5.18M
Net profit margin
-287.14%
-346.58%
7.22%
-91.07%
Earnings per share
-2.70
-2.10
-
-
Interest and investment income
198.00K
222.00K
158.00K
179.00K
Interest expense
-45.00K
-75.00K
-51.00K
-4.00K
Net interest expenses
153.00K
147.00K
107.00K
175.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.54M
-7.46M
2.64M
-4.80M
Gain or loss from assets sale
-
51.00K
-20.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer